Leading the way in life science technologies
FEEDBURNER Genetics
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc., celebrating its 40th anniversary in 2021. Renowned for its comprehensive coverage, GEN delivers exclusive insights and analysis across the life sciences, focusing on areas such as drug discovery, bioprocessing, OMICS, translational medicine, and gene editing. The magazine features high-quality reporting on the latest industry news, cutting-edge tools, and scientific advancements, making it an indispensable resource for researchers and executives.
-
New Protein-Like Polymers Target, Degrade “Undruggable” Proteins Driving Cancer
-
Strategies for Addressing Resistance and Off-Target Toxicity in Antibody-Drug Conjugates
-
Beam Designs New Approach for Direct Correction of Mutations Causing PKU
-
Tamarind Bio Secures $13.6M Series A to Make AI More Accessible for Biology
-
AI Maps Subtle Human Pancreatic Tissue Changes Linked to Type 2 Diabetes
EN
MT
DE
FR
ES
IT